CLINICAL_TRIALS
trial_result
· 2020-01-03
Clinical Trial Update: A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381 [Phase 2]
Summary
A long-term extension study (NC19453) evaluated the safety and efficacy of RO4607381 in Phase 2 for coronary heart disease; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Coronary Heart Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-01-03